# Lead4Life PPP 2026 – Enabling Technologies for Clinical Introduction of Lead-212 **Funder:** KWF **Budget:** €0.5M–€2M per project (total pillar budget €2.0M) **Deadline:** 22 September 2026 (12:00 noon; full proposal phase. Matchmaking phase precedes full proposal. Institutes not yet registered must submit registration request at least 6 weeks before closing date.) **Duration:** Up to 4 years **Consortium:** Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory **Application:** 2-stage: matchmaking phase → full proposal (submit via KWF GMS by 22 Sep 2026) **Frequency:** One-off **Eligible countries:** NL **Official call:** https://www.kwf.nl/en/forresearchers/funding/lead4life **Last updated:** 4 Jul 2026 > **Recently updated:** catalog cleanup 2026-07-04: duplicate row (canonical sibling kept) ## Eligibility & scope Health~Holland PPP call for 1–6 projects on enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals (chelators, radiobiology, dosimetry, QC, hospital infrastructure). Requires a public-private consortium with signed Consortium Agreement and Health~Holland PPP compliance. Private party must not be an undertaking in difficulty (RVO declaration required). Clinical/patient-sample context likely. ## Summary The KWF Lead4Life PPP 2026 call funds enabling technologies for safe clinical introduction of Pb-212 radiopharmaceuticals, with budgets up to €2 million over four years per project. The call requires a mandatory public-private partnership consortium and targets research on chelators, radiobiology, dosimetry, quality control, and hospital infrastructure for Lead-212 therapies. One-off opportunity open to Dutch institutions; 1-6 projects will be funded. ## Who should apply - Academic or hospital-based research groups with radiochemistry, radiobiology, or dosimetry expertise - Dutch institutions eligible to coordinate or participate in a public-private consortium - Private-sector partners (pharma, device manufacturers) not in financial difficulty - Research focused on clinical translation: chelator development, quality control, hospital infrastructure for Pb-212 - Consortia with a signed Consortium Agreement in place before full proposal submission ## Key dates - Full proposal deadline: 22 September 2026, 12:00 noon (submit via KWF GMS) - Matchmaking phase precedes full proposal; institutes not yet registered must request registration at least 6 weeks before deadline (by 11 August 2026) - Up to four-year project duration ## Tips for applicants - The Consortium Agreement must be signed and submitted with the full proposal; do not delay legal agreements until after notification. - Private partners must obtain an RVO declaration confirming they are not an undertaking in difficulty; budget time for this bureaucratic step. - Lead with clinical feasibility and hospital readiness; KWF prioritises projects with clear pathway to patient access, not bench-only enabling research. ## Frequently asked questions ### What is the budget for the KWF Lead4Life PPP 2026? Up to €2 million per project over four years; the total pillar budget is €2.0 million, so 1-6 projects will be funded depending on scope. ### Who can apply for the Lead4Life PPP? Dutch academic and hospital-based research groups in a public-private consortium with a signed Consortium Agreement; private partners must not be in financial difficulty. ### What technologies does the Lead4Life PPP fund? Enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals, including chelators, radiobiology, dosimetry, quality control, and hospital infrastructure. ### Is the Consortium Agreement required before submitting the full proposal? Yes, the signed Consortium Agreement is mandatory and must be submitted with the full proposal. ### When is the full proposal deadline for Lead4Life PPP 2026? 22 September 2026 at 12:00 noon via KWF GMS; a matchmaking phase precedes the full proposal stage. --- Source: [The Great Grantsby](https://grantsby.eu/grants/kwf-lead4life-ppp-2026-enabling-technologies-for-clini) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying. **See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=kwf-lead4life-ppp-2026-enabling-technologies-for-clini).